Research & Projects

ESCMID Panorama

ESCMID Vaccine Study Group - EVASG

News & Activities

05 April 2017

EVASG @ ECCMID 2017 in Vienna, Austria

  • EVASG Meeting, Sunday, 23 April, 13.15 - 14.15, Hall B Gallery 1 a+b
  • Saturday, 9 April 2016
    11.00 h - 13.00 h (Hall I)
    2-hour Educational Workshop EW018: Update on vaccines and vaccination
    13.30 h - 15.30 h (Hall I)
    2-hour Symposium SY025: Immunity and vaccination in advanced age
  • Sunday, 10 April 2016
    13.15 h - 14.15 h (Room: Amsterdam Suite)
    EVASG Meeting: All interested persons are cordially invited to join the meeting and plan future Study Group activities.
  • Tuesday, 12 April 2016
    9.00 h - 11.00 h (Hall E)
    2-hour Symposium SY130: Combatting biofilm infections: from basic research to clinical practice
    11.30 h - 12.30 h (Hall K)
    1-hour Symposium SY142: Recent top papers in paediatric infectious diseases

Press release: The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) is calling on the healthcare industry to lead by example and implement universal flu vaccination for healthcare workers. ESCMID is encouraging all health workers to take personal responsibility and get vaccinated this season, particularly those who come into contact with high-risk groups.

 

download press release

  • Saturday, 25 April 2015
    08.45 - 10.45 (Hall F)
    EVASG Educational Workshop EW06: How to improve compliance with vaccination? Organized jointly with the Elderly Infections Group (ESGIE).
    11.00 - 13.00 (Hall F)
    EVASG Educational Workshop EW15: Vaccination of immunocompromised and allergic patients - are we missing the obvious? Organized jointly with the Compromised Hosts Group (ESGICH) and the Trainees Association of ESCMID (TAE).
    13.30 - 15.30 (Hall F)
    EVASG Symposium SY04: Vaccines against mucosal infections.
  • Sunday, 26 April 2015
    13.15 - 14.15 (Room 24/25)
    EVASG Business Meeting: All interested persons are cordially invited to join the meeting and plan future Study Group activities.
    14.30 - 15.30 (Hall F)
    EVASG Symposium SY19: Pneumococcal conjugate vaccine for adults - Pro-Con debate.
    14.30 - 15.30 (Hall J)
    EVASG Symposium SY21: Efficacy and side effects of neuraminidase inhibitors for influenza: who should be treated and who not? Organized jointly with the Elderly Infections Group (ESGIE).
  • Saturday, 10 May 2014
    08.45 - 10.45 (Hall E)
    Educational Workshop 04: Vaccination in the elderly: perspectives, organised jointly with the ESCMID Study Group for Infections in the Elderly (ESGIE).
  • Monday, 12 May 2014
    13.15 - 14.15 (Room 124)
    EVASG Business Meeting: All interested persons are cordially invited to join the meeting and plan future Study Group activities.
  • Tuesday, 13 May 2014
    7.45 - 8.45 (Hall G)
    EVASG Meet-the-Expert Session: Healthcare providers and influenza vaccination.
    13.30 - 15.30 (Hall B)
    EVASG Symposium: Hot topics in vaccine-preventable diseases.

For the first time, a Chinese-made vaccine receives World Health Organization endorsement. The vaccine – formally known as SA 14-14-2 – protects children against Japanese encephalitis, a viral brain infection common in parts of east and south Asia.

Other Chinese-made vaccines are on the same tracks, like Hecolin, a hepatitis E vaccine, that was presented – for the first time on European soil – at the ESCMID Conference on the Impact of Vaccines on Public Health earlier this year. The presentation is freely available on the ESCMID website.

New ESCMID Study Group

EVASG is a newly formed ESCMID Study Group, which has started its activities in the field of vaccinology. The inauguration meeting was held at ECCMID 2013 in Berlin, DE.

Objectives of EVASG

Contact

Last update: 05 April 2017

Download the latest Annual Report.